All lentiviral particles (the Product) are subject to the following policy. In this Policy, Customers of GeneCopoeia products are referred to as Buyers and distributors who sell GeneCopoeia products are referred to as Resellers.
GeneCopoeia quality assurance policy ensures that the initial titer in copies/ml of genomic RNA for the lentiviral particles purchased will be as indicated in the accompanied datasheet. However, GeneCopoeia does not guarantee the transduction results obtained for specific target cells as the transducibility may vary from one cell type to another.
A limited use license is granted to the Buyer of the Product. The Product shall be used by the Buyer for internal research purposes only and should not be transferred (in any way) to any third party. The Product is expressly not designed, intended, or warranted for clinical use in humans or for therapeutic or diagnostic use. The Product must notbe resold, repackaged or modified for resale, or used to manufacture commercial products without prior written consent from GeneCopoeia. This Product should be used in accordance with the NIH guidelines developed for recombinant DNA and genetic research. Use of any part of the Product constitutes acceptance of the above terms.